In particular, the present study investigated the RXRα isoform, which has been suggested as a potential therapeutic target in breast cancer cells, due to the observation that overexpression of RXRα sensitized breast cancer cells lines to the antiproliferative effects of RXR-selective ligands (24). The gene discussed is RXRA; the disease is breast cancer.